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ODACH: a one‑shot distributed
algorithm for Cox model
with heterogeneous multi‑center
data
Chongliang Luo1,2, Rui Duan3, Adam C. Naj2,4, Henry R. Kranzler5, Jiang Bian6 & Yong Chen2*
We developed a One-shot Distributed Algorithm for Cox proportional-hazards model to analyze
Heterogeneous multi-center time-to-event data (ODACH) circumventing the need for sharing
patient-level information across sites. This algorithm implements a surrogate likelihood function to
approximate the Cox log-partial likelihood function that is stratified by site using patient-level data
from a lead site and aggregated information from other sites, allowing the baseline hazard functions
and the distribution of covariates to vary across sites. Simulation studies and application to a realworld opioid use disorder study showed that ODACH provides estimates close to the pooled estimator,
which analyzes patient-level data directly from all sites via a stratified Cox model. Compared to the
estimator from meta-analysis, the inverse variance-weighted average of the site-specific estimates,
ODACH estimator demonstrates less susceptibility to bias, especially when the event is rare. ODACH
is thus a valuable privacy-preserving and communication-efficient method for analyzing multi-center
time-to-event data.
Real-world data (RWD) such as electronic health records (EHRs) and medical claims, are used increasingly
to provide evidence-based support for healthcare decision m
 aking1–3. The past decade has seen an increasing
number of clinical research networks that accumulate and promote the use of large collections of RWD for
clinical research. For example, the international Observational Health Data Sciences and Informatics (OHDSI)
collaborative4, and the national Patient-Centered Clinical Research Network (PCORnet) in the United S tates5,
both cover hundreds of millions of patients. These large data consortia provide opportunities to integrate RWD
from various healthcare organizations. Multicenter analyses using RWD from these clinical research networks
have expanded rapidly because of improved generalizability from more representative population samples and
increased statistical power to detect modest associations between exposures and outcomes.
Despite the benefits of multicenter analyses, two major challenges exist for multi-site data integration. First,
the direct sharing of patient-level data across institutions may be prohibited, as individual patient-level data are
protected by privacy regulations such as the Health Insurance Portability and Accountability Act (HIPAA) in
the United States or the European Union’s General Data Protection Regulation (GDPR). Hence many research
networks such as OHDSI and PCORnet have adopted a federated model in which patient-level data are stored
at local institutions and often only aggregated information are shared across s ites5–7. Second, data from different
sites are often heterogeneous with respect to patient characteristics, data quality, and other unobserved sitespecific features. Assuming that a common statistical model is appropriate across all sites may result in biased
estimation and poor prediction.
Within these clinical research networks, the abundance of EHRs containing data on patients at multiple time
points is especially useful for survival analyses, which model the time to a specific outcome or event of interest.
To conduct multicenter survival analyses without sharing patient-level data, a common and convenient approach
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Figure 1.  Schematic illustration of the ODACH algorithm. The first step is initialization, where each site reports
j). The lead site then
the local estimation of the log hazard ratio (βj) and the corresponding variance estimate (V
computes the initial estimate β as the weighted average of all local estimates and sends it back to each site. In the
second step, each site calculates and shares the local gradients ∇Lj (β) and ∇ 2 Lj (β). In the third step, the lead
∼
site constructs a surrogate likelihood function L̃(β) with these gradients and obtains the surrogate estimate β .
is meta-analysis, where a weighted average of the local estimates from each site is used. However, when the
outcomes or exposures are rare, or the samples at some sites are small, the accuracy of the meta-analysis may be
low8,9. To obtain more accurate results under these conditions, distributed algorithms have been developed, such
as the WebDISCO (a web service for distributed Cox model learning)10. Despite providing identical results to
that from pooling individual-level data (“lossless”), this algorithm is communication intensive due to its iterative
nature, which requires multiple rounds of communications across sites. To balance communication efficiency
and estimation accuracy, Shu et al.11 proposed a lossless one-shot algorithm for a stratified Cox model that can
include only one binary covariate in the model. Huang and H
 uo12 proposed a distributed one-step estimator
to improve the accuracy of meta-analysis estimator. Wang et al.13 proposed a “divide-and-conquer approach,”
aiming to reduce the computational burden when the sample size is extremely large. Duan et al.9 proposed a
One-shot Distributed Algorithm for Cox model (ODAC) based on the surrogate likelihood approach that relies
on patient-level data from a single site and aggregated data from other sites. This algorithm requires aggregated
data from only two iterations but obtains estimates close to those resulting from the inclusion of patient-level
data from all sites.
Most of these approaches are based on the Cox proportional-hazards model, with a few accounting for
between-site heterogeneity. Specifically, in multicenter survival analyses, baseline hazard functions and the
distribution of covariates are likely to differ across sites as patients often come from different sub-populations
varying in racial/ethnic compositions across geographic regions. Ignoring the heterogeneity across sites could
lead to biased estimated associations. Here we propose a distributed algorithm that accounts for site-level heterogeneities in covariate distributions and baseline hazard functions, the One-shot Distributed Algorithm for
Cox model with Heterogeneity (ODACH). Compared to the previously described ODAC, which assumes a
common baseline hazard function across sites, ODACH assumes heterogeneous baseline hazard functions, and
is therefore more flexible and practical in real-world settings. Moreover, unlike ODAC, the use of a constructed
surrogate likelihood means that ODACH does not require an extra round of communication regarding the risk
set in each site, improving communication efficiency. We illustrate in a simulation study and in a real-world
multicenter opioid use disorder study that our proposed algorithm is both a ‘one-shot’ approach and highly
accurate (i.e., demonstrates less bias).

Results

A one‑shot distributed algorithm for cox model with heterogeneity. The proposed ODACH
algorithm constructs a surrogate log-likelihood function to approximate the log-likelihood function of the stratified Cox model, which is commonly used to account for site-specific baseline hazards when analyzing multi-site
time-to-event outcomes. We provide a schematic illustration of the ODACH algorithm in Fig. 1.
ODACH can reduce estimation bias in multicenter survival analyses. We used a simulation study
to demonstrate the bias-reduction property of the proposed ODACH algorithm in multicenter survival analyses, especially when the outcome is rare. We generated time-to-event outcomes that are associated with two
covariates. The pooled data are evenly distributed to K = 10 clinical sites. Details of the data generation are in
the “Methods” section. We applied three approaches to estimate the HRs of the two covariates on the time-toScientific Reports |
Vol:.(1234567890)
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Figure 2.  Boxplot of bias relative to the gold standard (stratified Cox model on the pooled dataset across all
sites). The two methods compared in the plot are meta-analysis (meta) and One-shot Distributed Algorithm for
Cox model with Heterogeneous baseline hazards (ODACH). The event rate varies from 20 to 1% and under each
setting the boxplots are based on 200 replications of the simulation. The true effect size is 1.

event outcome, i.e., pooled stratified Cox regression, meta-analysis, and the proposed ODACH method. Because
the pooled Cox regression estimator can be considered a gold standard, the relative bias of meta-analysis and
ODACH estimates to the pooled estimate are compared to demonstrate the advantage of ODACH.
Results of the simulation show that ODACH achieves better estimation performance than the meta-analysis
estimator, especially for a rare event. Figure 2 shows that ODACH yields relative biases close to 0, meaning that
it provides results almost identical to those of the pooled estimator, i.e., by stratified Cox model on the pooled
dataset across all sites. As the event becomes rarer, the meta-analysis estimator is observed to have a larger bias.
For example, when the event rate is 1%, the average relative bias is around − 11% for the meta-analysis estimator, but is negligible for the ODACH estimator. Moreover, the variation of the meta-analysis estimator is much
larger than that of the ODACH estimator.

The OneFlorida opioid use disorder study.

We demonstrate the use and advantage of the proposed
ODACH method by studying the association of time to an opioid use disorder (OUD) diagnosis with risk factors (e.g., patients’ demographic and clinical characteristics) using RWD from the OneFlorida Clinical Research
Consortium. A detailed description of the data and the risk factors are in the “Methods” section.
Figure 3 shows the estimated log HRs of the seven risk factors from the pooled analysis (stratified Cox model),
meta-analysis, and the proposed ODACH analysis and their 95% confidence intervals (CIs). The ODACH provides HR estimates that are nearly identical to the pooled estimates for all of the risk factors. As a comparison,
meta-analysis estimates have substantial biases relative to the pooled estimator, especially for the effects of age,
smoking status, and pain history. For example, the estimated log HR of pain history is 0.554 from the pooled
analysis, 1.097 from the meta-analysis, and 0.491 from the ODACH estimator. The relative bias is 98.0% for the
meta-analysis estimator and − 11.4% for the ODACH estimator. Moreover, the quantitatively larger biases of
meta-analysis estimates may lead to qualitatively different statistical significance. For example, with a significance threshold α = 0.05, the effect of pain history on time to OUD diagnosis is considered statistically significant (p = 0.001) per the meta-analysis estimator, but not statistically significant per either the pooled analysis
(p = 0.061) or the ODACH estimator (p = 0.111).

Discussion

We developed a privacy-preserving One-shot Distributed Algorithm for the Cox model to analyze Heterogeneous multicenter time-to-event data (ODACH). The proposed surrogate likelihood approach approximates the
log partial likelihood of the stratified Cox model that uses patient-level data from all of the sites. The simulation
study and application to the real-world OneFlorida OUD study both show that the surrogate estimation yields
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Figure 3.  Comparison of estimation biases by meta-analysis and ODACH in the opioid use disorder study.
Presented are the estimated log hazard ratios (HRs) with 95% confidence intervals for risk factors for opioid
use disorder using pooled analysis (blue), meta-analysis (green), and One-shot Distributed Algorithm for
multicenter Cox proportional hazards model with heterogeneous hazard (ODACH) (red). The analyses used
data of N = 14,015 patients from five clinical sites in the OneFlorida Clinical Research Consortium.

results that are closer than the typical meta-analysis approach to the pooled analysis results, especially when
the event is rare. As suggested by a reviewer, simulation results comparing more approaches are deferred in the
Supplementary Information. Compared to the existing One-shot Distributed Algorithm for Cox model (ODAC),
ODACH allows baseline hazard functions and covariate distributions to be site specific, and hence it is more
flexible in its application.
RWD play an increasing role in generating real-world evidence to support healthcare decision making.
Observational RWD such as those from EHRs and medical claims contain longitudinal information, which enables time-to-event modeling such as through the Cox proportional-hazards model, one of the most commonly
used models for time-to-event analysis in observational studies that evaluate treatment effects and identify risk
factors. In multicenter studies, when sharing patient-level data across databases is not possible, the individual
estimates from each database are integrated through a meta-analysis approach. Our proposed distributed algorithm could provide a better alternative to the commonly used meta-analysis, with particular benefits in the case
of rare events. The algorithm is implemented in the R package “pda”14. A demo example is available at https://
github.com/Penncil/ODACH.
There are several directions for future work. For instance, time-varying covariates or time-varying effects are
sometimes encountered in time-to-event a nalyses15,16. Under these conditions, because the Cox model relaxes the
usual proportional hazards assumption but requires additional data for accurate estimation17,18, the development
of a distributed algorithm for the Cox model with time-varying covariates or time-varying effects in multi-center
studies would be desirable. Moreover, in certain settings, other survival models such as the accelerated failure
time (AFT) model19 are more appropriate than the Cox model. A distributed algorithm for the AFT model is
currently under investigation and will be reported in the future. In addition, because sources of heterogeneity
other than baseline hazard functions or distributions might exist, such as missing data patterns and site-specific
effect sizes, robust methods for handling different types of h
 eterogeneity20–22 are needed to avoid potentially
misleading results.

Methods

The ODACH algorithm. Suppose that we have study subjects from K different clinical sites
 and denote nj
to be the number of subjects in the j-th site. We denote the total number of subjects as N = Kj=1 nj . For the
i-th subject in the j-th site, we observe {Tij , δij , xij }, where Tij is the observed time to event, xij is a p-dimensional covariate variable, and δij = 0 indicates censoring and δij = 1 indicates an event. The Cox proportional
that the hazard of the i-th subject in the j-th site having the event at time t as
hazard model
 describes


 t|xij = j (t)exp β T xij . We assume that the log hazard ratio (HR) β is the same across all sites, i.e., there
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are common effects of the covariates on the time-to-event across sites. The stratified log Cox partial likelihood
function is

L(β) =

K
1 
nj Lj (β),
N

(1)

j=1

where Lj (β) is the log Cox partial likelihood function for the j-th site,


nj
exp β T xij
1 

,
Lj (β) =
δij log 
T
nj
s∈Rj (Tij ) exp β xsj
i=1

(2)

where Rj (t) is the risk set in site j at time t defined as Rj (t) = {i; Tij ≥ t}, which contains all of the subjects in
site j who have not experienced an event or been censored at time t . The common effect β can be estimated
by maximizing (1), i.e., β = argmaxβ L(β). We call this the pooled estimator, as it requires all of the data to be
pooled together.
In practice, it is often difficult to transfer patient-level data across sites, hence the pooled estimate β can be
hard to obtain. Inspired by the previously-developed surrogate likelihood approach8,9,23, we aimed to construct
a proxy of the stratified Cox partial likelihood function (1), using only summary-level information from other
sites. We assume we have access only to the patient-level data from a lead site (e.g., the first site). The ODACH
surrogate likelihood function is constructed as

 
T
 

 
 
1
L̃(β) = L1 (β) + �∇L β − ∇L1 β , β� + β − β {∇ 2 L β − ∇ 2 L1 β } β − β ,
2

(3)

2
where L1 (β) is the log-likelihood function of the lead
the first and second order gra  site, and
 ∇ and ∇ denote

dients of a function (explicit forms of ∇Lj β , ∇L β , ∇ 2 Lj β and ∇ 2 L β can be found in the Supplementary
Materials). β is an initial value that is close to the true value of β, e.g. the inverse variance-weighted average of
the estimates obtained by fitting a Cox model at each site,

−1
K
K
�
�
� −1 
� −1 β�j ,
β=
V
V
(4)
j
j
j=1

j=1

j is the estimated
where βj = argmax β Lj (β) is the estimator of the Cox model fitted on data at the ∼j-th site, and V
variance of βj . The surrogate estimator is thus obtained by maximizing (3), i.e., β= argmaxβ L̃(β).
Intuitively, the surrogate likelihood function (3) modifies the likelihood function L1 (β) of the lead site to
approximate
the
likelihood
being

T (1), with
  the modification
 
 the first- and second-order terms, i.e.,
 
 stratified

�∇L β − ∇L1 β , β� and 12 β − β {∇ 2 L β − ∇ 2 L1 β } β − β . By sharing the second-order gradients, our
method allows each
of
 site
 to have different covariate distributions.
 the
 In
 the construction
 surrogate likelihood
K
r L β can be calculated distributively by ∇ r L β = 1
r L β , for r = 1, 2 . Because
function
(3),
∇
n
∇
j
j
j=1
 
 
N
from the lead site, it only requires other collaborative sites to calculate and
∇L1 β and∇ 2L1 β areavailable

2
transfer ∇Lj β and ∇ Lj β , j = 2, . . . , K. As these gradients are all aggregated information, patient-level information is protected. We summarize the ODACH algorithm in the box below.
Note that we assume the first site is the lead site when constructing the surrogate likelihood. In practice, if any
site can serve
 as the lead site, we recommend using the largest site for this purpose. Alternatively, after the derivatives ∇ r Lj β , r = 1, 2, j = . . . , K have been shared across sites, each site can serve as the lead site and obtain its
own surrogate estimate. These surrogate estimates can be further synthesized to obtain more accurate estimation.
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Figure 4.  The baseline survival functions of the 10 sites in the simulated data. The varying hazard functions are
Weibull functions with scale and shape parameters as listed.

Simulation study. We evaluated the performance of the proposed ODACH estimator using simulated
multi-site time-to-event data. A pooled dataset of N = 5000 subjects was generated based on a Weibull proportional hazards model, where the baseline hazard follows a Weibull distribution with varying scale and shape
parameters. Specifically, the scale parameters range from 100 to 280 and are equally spaced. The shape parameters range from 20 to 0.5, spaced equally in the logarithmic scale (see Fig. 4 for an illustration). We generated
two covariates from uniform distributions and the true log HRs were set to be β = (− 1, 1). We set the event rate
(number of cases over number of subjects) as 20%, 2% or 1% by generating censoring times following appropriate distributions. The pooled data were evenly distributed to K = 10 clinical sites, with 500 subjects in each site.
We applied three approaches to estimate the HRs of the two covariates on the time-to-event outcome, i.e., pooled
stratified Cox regression, meta-analysis, and the proposed ODACH method. Because the pooled Cox regression estimator can be considered a gold standard, the relative bias of meta-analysis and ODACH estimates to
the pooled estimate are compared to demonstrate the advantage of ODACH. The simulation was replicated 200
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Site

Site 1

Site 2

Site 3

Site 4

Site 5

Total, N (%)

4078 (100)

3354 (100)

2367 (100)

2296 (100)

1920 (100)

Age ≥ 65 years, N (%)

602 (14.8)

562 (16.8)

464 (19.6)

433 (18.9)

229 (11.9)

Male, N (%)

1560 (38.3)

1142 (34)

972 (41.1)

799 (34.8)

530 (27.6)

NHW, N (%)

2510 (61.5)

1643 (49)

234 (9.9)

1406 (61.2)

889 (46.3)

Current smoker, N (%)

714 (17.5)

61 (1.8)

1 (0)

297 (12.9)

99 (5.2)

CCI, mean (S.D.)

0.86 (1.64)

0.69 (1.39)

0.97 (1.82)

0.79 (1.56)

0.75 (1.35)

Depression, N (%)

415 (10.2)

196 (5.8)

232 (9.8)

262 (11.4)

155 (8.1)

Pain, N (%)

636 (15.6)

392 (11.7)

252 (10.6)

248 (10.8)

385 (20.1)

OUD, N (%)

19 (0.5)

15 (0.4)

11 (0.5)

11 (0.5)

12 (0.6)

Table 1.  Characteristics of the patients from five OneFlorida clinical sites. NHW non-Hispanic White, CCI
Charlson comorbidity index, OUD opioid use disorder.

times. For simplicity of illustration, we present only the results for the estimation of coefficient β2, as the results
for the other coefficient are similar.

The OneFlorida opioid use disorder study.

We evaluated the use and advantage of the proposed
ODACH method by studying the association of time to an opioid use disorder (OUD) diagnosis with risk factors using RWD from the OneFlorida Clinical Research Consortium. A total of 14,015 subjects were sampled
from five clinical sites and followed for 3 years after their index opioid prescription for chronic non-cancer pain
(CNCP) and the time to the diagnosis of OUD was recorded. A summary of the patients’ age (65 + vs. 18–65),
gender (male vs. female), race (Non-Hispanic White (NHW) vs. others), smoking status (current smoker vs.
others), CCI (Charlson comorbidity index24, a weighted score of comorbid conditions), depression, and pain
history measured at the index date are shown in Table 1. The rates of OUD are < 1% at all sites.

Use of experimental animals, and human participants. The use of human subject HIPAA limited

data set was approved by the University of Florida (UF) Institute Review Board (IRB) under the protocol number
IRB202001100. The University of Florida Federalwide Assurance number is FWA00005790. The study protocol
has been reviewed by the UF IRB in accordance with the institutional and federal guidelines. Both Waivers of
Informed Consent and HIPAA Waiver of Authorization were granted by the Institutional Review Board of the
University of Florida.
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